SHED review: the widest oral GLP-1 selection

If you only remember one thing about SHED: they sell more oral GLP-1 formats than any other telehealth platform we've reviewed. Four separate compounded formats (sublingual drops, lozenges, oral liposomal tablets, and gummies) plus a referral pathway for the brand-name Wegovy pill. That breadth is either SHED's greatest asset or its biggest liability, depending on how you think about the market.

Company background

SHED is a direct-to-consumer telehealth platform operating in all 50 U.S. states. As of April 2026, the company reports membership exceeding 150,000 patients — a significant scale for a telehealth weight-loss operation. SHED is privately held and doesn't publish SEC filings the way a public company like MangoRx does, so financial transparency is limited to what the company chooses to disclose.

The company's regulatory posture is among the better in the compounded GLP-1 space. SHED holds LegitScript certification — a third-party compliance accreditation that's increasingly a minimum-viable-trust signal for legitimate compounders. They operate under HIPAA, they publish their pharmacy partners in materials available to members, and they have not (as of our April 2026 review) been the subject of an FDA warning letter.

The four compounded oral formats

SHED's breadth is what makes them distinctive. Each format has a different pharmacokinetic profile and practical tradeoff:

1. Sublingual drops

A dropper of compounded semaglutide held under the tongue for 60–90 seconds before swallowing any remainder. The most common starter format. Dosing is flexible but depends on the pharmacy's specific concentration. SHED's drops start around $229/month at typical starter concentrations.

What the evidence says: sublingual administration can produce meaningful absorption of some small peptides, but semaglutide-specific human pharmacokinetic data for sublingual drops is essentially absent. The theoretical mechanism is plausible; the clinical outcome data is extrapolated.

2. Lozenges (troches)

Slowly-dissolving flavored lozenges that deliver semaglutide gradually over several minutes. The longer dwell time in the mouth theoretically allows for more sublingual absorption than rapid-dissolve formats. Priced similarly to drops.

3. Oral liposomal tablets

Compounded tablets formulated with liposomal carriers — small lipid vesicles designed to protect the peptide from degradation and potentially improve absorption. The liposomal approach has been explored academically for oral peptide delivery for years. As with other compounded formats, there are no published human efficacy trials specific to this formulation.

4. Gummies

Flavored chewable gummies containing compounded semaglutide. Attractive for patients who struggle with swallowing pills or who simply find gummy formats more palatable. Absorption mechanism is a mix of sublingual (during chewing) and gastrointestinal (after swallowing).

The brand Wegovy pill referral path

This is where SHED differs most from pure compounders like MangoRx or Wellorithm. SHED offers a referral pathway for patients who want the FDA-approved Wegovy pill instead of compounded alternatives. The mechanics: SHED's clinicians can prescribe the Wegovy pill and route the prescription to a standard pharmacy under NovoCare Direct pricing ($149/month starter, $299/month maintenance).

For patients who are ambivalent about compounded products, this is a meaningful feature. You can start the SHED relationship knowing that if the compounded formats don't work for you, there's a brand-name escape hatch within the same platform.

The 10% body-weight guarantee

SHED markets a money-back guarantee: if you don't lose at least 10% of your starting body weight within a 9-month window, they refund a portion of what you paid. This is marketing-forward but worth reading the fine print on.

What we've confirmed from public materials:

• The guarantee typically requires consistent program adherence — meaning you must have taken the medication as prescribed for the full period, not stopped partway through
• You must have attended the required check-ins (monthly or quarterly telehealth visits)
• The refund is typically for the medication portion of what you paid — not always the full program cost including consults and shipping
• Qualifying body weight and body composition must be documented through specified methods

It's a real guarantee with real fine print. About 69–86% of people in trials reach 10% weight loss at matched doses of semaglutide in at least 64 weeks — so for most adherent patients, the guarantee won't be needed. For people who discontinue early (which is a significant fraction in real-world use), the guarantee terms typically won't apply because the adherence requirement isn't met.

Pricing across formats

The compounded pricing is mid-market — more expensive than the cheapest compounders (Wellorithm at $147, Care Bare Rx at $199) but cheaper than premium competitors. The real pricing story is the Wegovy pill pathway, which gets you to the same NovoCare pricing you'd pay going direct through Novo Nordisk or Sesame Care.

The compliance picture

SHED's compliance posture compares favorably to most compounded GLP-1 telehealth platforms:

• LegitScript certified — an important third-party compliance signal
• HIPAA-compliant — baseline expectation for any telehealth
• No FDA warning letter as of our April 2026 review (MEDVi, Strut Health, SkinnyRx, and 24hrDoc all received warning letters in February 2026; SHED did not)
• Identifiable pharmacy partners — the compounding pharmacies that fill SHED prescriptions are named in member-facing materials
• Active marketing audits — the company publicly disclosed revising marketing language in early 2026 in response to industry-wide regulatory changes

None of that makes compounded products FDA-approved (they aren't), but it does put SHED in the compliance-forward tier of compounded telehealth.

Who SHED is best for

Editorial verdict

SHED is the best-in-class compounded oral GLP-1 provider for patients who value format variety and the brand-pill backstop. If you already know you want the Wegovy pill specifically, start at Sesame Care. For everyone else, SHED is a strong default.

The ideal SHED user profile is someone who wants to try a compounded oral format but values having FDA-approved alternatives on the same platform as insurance. Someone who's not sure whether drops, lozenges, or tablets will feel right. Someone who wants LegitScript-grade compliance without paying premium prices. For that person, SHED is one of the best options we've reviewed.

What SHED isn't: the cheapest oral GLP-1 option (that's Wellorithm), the most transparent corporate structure (that's MangoRx), or the cleanest regulatory path (that's Sesame Care, which is brand-name only). It's the most versatile provider, and for patients who value optionality, that's worth paying for.

Alternatives to consider

• Sesame Care — if you want FDA-approved oral GLP-1 only, no compounded products
• MangoRx — if you want an oral-only platform with clearer corporate transparency (NASDAQ: MGRX)
• Wellorithm — if you want the cheapest compounded oral semaglutide available ($147/mo) and are comfortable with less format variety and less corporate scale